- Home
- EIKN vs BME Comparison
EIKN vs BME Comparison
Compare EIKN & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIKN | BME |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.0M | 576.8M |
| IPO Year | 2026 | 2005 |
Fundamental Metrics
Financial Performance| Metric | EIKN | BME |
|---|---|---|
| Price | $7.26 | $44.29 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $24.60 | N/A |
| AVG Volume (30 Days) | ★ 626.1K | 35.4K |
| Earning Date | 11-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.02 | $37.37 |
| 52 Week High | $16.50 | $46.43 |
Technical Indicators
Market Signals| Indicator | EIKN | BME |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 53.56 |
| Support Level | $7.02 | $43.85 |
| Resistance Level | $10.20 | $45.07 |
| Average True Range (ATR) | 0.54 | 0.63 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 12.21 | 75.13 |
Price Performance
Historical ComparisonAbout EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.